K. Newbold

1.0k total citations
33 papers, 803 citations indexed

About

K. Newbold is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, K. Newbold has authored 33 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Otorhinolaryngology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in K. Newbold's work include Head and Neck Cancer Studies (24 papers), Oral health in cancer treatment (7 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). K. Newbold is often cited by papers focused on Head and Neck Cancer Studies (24 papers), Oral health in cancer treatment (7 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). K. Newbold collaborates with scholars based in United Kingdom, Netherlands and Italy. K. Newbold's co-authors include Kevin J. Harrington, Christopher M. Nutting, Shreerang Bhide, Merina Ahmed, Yolanda Barbáchano, Angela M. Riddell, Ulrike Schick, Richard Marais, Amaya Virós and Ceri Powell and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and British Journal of Cancer.

In The Last Decade

K. Newbold

32 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Newbold United Kingdom	16	324	227	202	185	172	33	803
Kam‐Tong Yuen China	9	662 2.0×	243 1.1×	374 1.9×	173 0.9×	51 0.3×	16	992
Chengrun Du China	14	300 0.9×	127 0.6×	190 0.9×	27 0.1×	131 0.8×	32	521
Kitty Y. Wan China	8	272 0.8×	94 0.4×	229 1.1×	182 1.0×	17 0.1×	12	582
Hsing‐Lung Chao Taiwan	17	209 0.6×	283 1.2×	200 1.0×	21 0.1×	106 0.6×	36	764
Gregor J. Förster Germany	11	58 0.2×	103 0.5×	83 0.4×	56 0.3×	270 1.6×	18	482
Tommy Sheu United States	10	32 0.1×	194 0.9×	134 0.7×	51 0.3×	75 0.4×	23	418
Pierre Boisselier France	11	173 0.5×	257 1.1×	96 0.5×	10 0.1×	128 0.7×	22	520
Ieta D’Costa Australia	12	191 0.6×	148 0.7×	130 0.6×	7 0.0×	82 0.5×	24	517
Kathy Rock Ireland	10	148 0.5×	173 0.8×	160 0.8×	10 0.1×	59 0.3×	22	568
M.-L. Sautter-Bihl Germany	13	46 0.1×	173 0.8×	192 1.0×	13 0.1×	343 2.0×	26	766

Countries citing papers authored by K. Newbold

Since Specialization

Citations

This map shows the geographic impact of K. Newbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Newbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Newbold more than expected).

Fields of papers citing papers by K. Newbold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Newbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Newbold. The network helps show where K. Newbold may publish in the future.

Co-authorship network of co-authors of K. Newbold

This figure shows the co-authorship network connecting the top 25 collaborators of K. Newbold. A scholar is included among the top collaborators of K. Newbold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Newbold. K. Newbold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Newbold, K., Baktiar Hasan, Laura D. Locati, et al.. (2020). 1919P Nintedanib (BIBF1120) after first line therapy in progressive medullary thyroid cancer: A multicenter EORTC prospective randomized double-blind phase II study (NCT01788982). Annals of Oncology. 31. S1087–S1088. 1 indexed citations

García-Murillas, Isaac, Rosalind Cutts, David González de Castro, et al.. (2017). Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma. British Journal of Cancer. 117(6). 876–883. 103 indexed citations

Mohamed, Abdallah, K. Newbold, Irene Karam, et al.. (2017). Large Interobserver Variation in the International MR-LINAC Oropharyngeal Carcinoma Delineation Study. International Journal of Radiation Oncology*Biology*Physics. 99(2). E639–E640. 7 indexed citations

Dean, Jamie, Liam Welsh, Kee H. Wong, et al.. (2017). Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clinical Oncology. 29(4). 263–273. 28 indexed citations

Barker, Holly E., Radhika Patel, Martin McLaughlin, et al.. (2016). CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy. Molecular Cancer Therapeutics. 15(9). 2042–2054. 40 indexed citations

Wong, Kee H., Liam Welsh, Dualta Mcquaid, et al.. (2016). Metabolic Tumor Volume Changes Measured by 18F-FDG-PET/CT After 1 Cycle of Induction Chemotherapy Is an Early Predictor of Radical Chemoradiation Therapy Outcome in Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 94(4). 920–921. 2 indexed citations

Mcquaid, Dualta, Alex Dunlop, Simeon Nill, et al.. (2016). Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers. Strahlentherapie und Onkologie. 192(8). 516–525. 8 indexed citations

Otter, Sophie, Ulrike Schick, S. Gulliford, et al.. (2015). Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. International Journal of Radiation Oncology*Biology*Physics. 93(3). 507–515. 33 indexed citations

Schmidt, Maria A., Ceri Powell, Dow‐Mu Koh, et al.. (2015). Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data. PLoS ONE. 10(9). e0138545–e0138545. 6 indexed citations

10.

Lynch, Joanna, Punita Lal, Ulrike Schick, et al.. (2014). Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral Oncology. 50(9). 901–906. 32 indexed citations

11.

Newbold, K., et al.. (2012). Prospective intra-patient evaluation of a shoulder retraction device for radiotherapy in head and neck cancer. Medical dosimetry. 37(3). 293–295. 2 indexed citations

12.

Partridge, Mike, et al.. (2012). Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy. British Journal of Radiology. 85(1020). 1576–1580. 3 indexed citations

13.

Bhide, Shreerang, S. Gulliford, Ulrike Schick, et al.. (2012). Dose–response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. Radiotherapy and Oncology. 103(1). 88–91. 42 indexed citations

14.

Newbold, K. & Ceri Powell. (2012). PET/CT in Radiotherapy Planning for Head and Neck Cancer. SHILAP Revista de lepidopterología. 2. 189–189. 25 indexed citations

15.

Ahmed, Merina, Yolanda Barbáchano, Angela M. Riddell, et al.. (2011). Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population. European Journal of Endocrinology. 165(2). 315–322. 160 indexed citations

16.

Hingorani, Mohan, Christine Spitzweg, Georges Vassaux, et al.. (2010). The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery. Current Cancer Drug Targets. 10(2). 242–267. 108 indexed citations

17.

Davies, Andrew, Jeremy Bagg, Marilène Filbet, et al.. (2009). Salivary gland dysfunction (‘dry mouth’) in patients with cancer: a consensus statement. European Journal of Cancer Care. 19(2). 172–177. 15 indexed citations

18.

Newbold, K., Mike Partridge, Gary Cook, et al.. (2008). Evaluation of the role of¹⁸FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta Oncologica. 47(7). 1229–1236. 19 indexed citations

19.

Bhide, Shreerang, Merina Ahmed, Yolanda Barbáchano, et al.. (2008). Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. British Journal of Cancer. 99(1). 57–62. 40 indexed citations

20.

Bowen, Joanne M., K. Newbold, Peter Blake, et al.. (2005). Do Serum Levels of Eosinophil Granule-derived Protein Change in Patients Undergoing Pelvic Radiotherapy?. Clinical Oncology. 17(5). 382–384. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact